Fusidic acid resistance determinants in Staphylococcus aureus clinical isolates
about
No decrease in susceptibility to NVC-422 in multiple-passage studies with methicillin-resistant Staphylococcus aureus, S. aureus, Pseudomonas aeruginosa, and Escherichia coliStructure and function of FusB: an elongation factor G-binding fusidic acid resistance protein active in ribosomal translocation and recyclingResponse of methicillin-resistant Staphylococcus aureus to amicoumacin AA genomic portrait of the emergence, evolution, and global spread of a methicillin-resistant Staphylococcus aureus pandemic.Fusidic acid resistance among clinical isolates of methicillin-resistant Staphylococcus aureus in a Taiwanese hospital.High diversity of genetic lineages and virulence genes in nasal Staphylococcus aureus isolates from donkeys destined to food consumption in Tunisia with predominance of the ruminant associated CC133 lineage.Identification of fusB-mediated fusidic acid resistance islands in Staphylococcus epidermidis isolates.No Outbreak of Vancomycin and Linezolid Resistance in Staphylococcal Pneumonia over a 10-Year Period.Dissemination of fusidic acid resistance among Staphylococcus aureus clinical isolatesSkin Commensal Staphylococci May Act as Reservoir for Fusidic Acid Resistance GenesIs the Colonisation of Staphylococcus aureus in Pets Associated with Their Close Contact with Owners?Shifts in the Clonal Distribution of Methicillin-Resistant Staphylococcus aureus in Kuwait Hospitals: 1992-2010New structure of phage-related islands carrying fusB and a virulence gene in fusidic acid-resistant Staphylococcus epidermidis.A novel staphylococcal cassette chromosomal element, SCCfusC, carrying fusC and speG in fusidic acid-resistant methicillin-resistant Staphylococcus aureus.A Critical Review of the Properties of Fusidic Acid and Analytical Methods for Its Determination.Fusidic Acid: A Bacterial Elongation Factor Inhibitor for the Oral Treatment of Acute and Chronic Staphylococcal Infections.Fusidic acid resistance in Staphylococcus aureus nasal carriage strains in nine European countries.Antimicrobial resistance of Staphylococcus aureus isolated from skin infections and its implications in various clinical conditions in Korea.Dissemination of macrolides, fusidic acid and mupirocin resistance among Staphylococcus aureus clinical isolates.The Microevolution and Epidemiology of Staphylococcus aureus Colonization during Atopic Eczema Disease Flare.Distribution of the Most Prevalent Spa Types among Clinical Isolates of Methicillin-Resistant and -Susceptible Staphylococcus aureus around the World: A Review.Observational cross-sectional study of nasal staphylococcal species of medical students of diverse geographical origin, prior to healthcare exposure: prevalence of SCCmec, fusC, fusB and the arginine catabolite mobile element (ACME) in the absence oStaphylococcus aureusand topical fusidic acid use: results of a clinical audit on antimicrobial resistanceCharacterization of rifampin-resistant nasal carriage in patients receiving rifampin-containing regimens for tuberculosis
P2860
Q24627750-3029F124-C7F6-4522-87C3-D4F0EA80C5EFQ27679364-8EEB3AED-3F8E-45E3-B17D-20C540AB902DQ28482069-DC48273C-DB6A-4A1C-8B7E-5269969AE924Q30425667-944E1D6B-0C4D-4298-B488-7A842B142859Q33898879-F3F2C27A-F414-4AFB-B9CE-21188D7C98BEQ34459559-5362E042-F751-4B8E-933D-63801C51B909Q35598394-92BBB1E9-C6E0-4A22-B3F4-87A3EF07BBF4Q35785093-74B1FCAE-C41C-49F0-9FD6-42B94EDE0090Q35805515-22043F04-A881-4E9F-8144-08357F05D129Q35845423-B4DDB77B-02EC-4E5B-837B-DF44272DEB21Q36030417-13AB86C0-45E7-49B8-A429-5FC0A654284CQ36134094-EB7F6D82-BCFE-4E9E-A56B-8222FEFBC4F5Q37263550-FAB9A04C-34BD-4728-95DF-2A01F48B04EBQ37544829-6A0E09B4-91BC-48FD-A538-002991DB89FEQ38580284-A29E0E0C-DB5A-4A70-A1EC-74FFA03AC19EQ38686596-1D2F90E3-288A-4ABC-B516-54138A0CF0E3Q39156366-2C17B41E-2C9E-482C-A9F9-00E819E47288Q39985562-98D44ABF-9D6E-4A6C-B448-69D542FC52EAQ41708953-376FAB8D-E416-40E5-9D1E-2E11C6022632Q46300215-DF323F45-C2F4-459E-A24F-11D3FF30E1CBQ50327973-97C5C8B0-A8F9-4F00-B3F8-8D7D3D251B06Q55450366-F84F15E6-F67C-458A-9AA5-801330D17CDEQ56880967-3F52867B-7150-4EEE-A1FD-BFC53A2F37F8Q58781899-4ED52FDA-A925-4F47-8852-0881509F49AD
P2860
Fusidic acid resistance determinants in Staphylococcus aureus clinical isolates
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Fusidic acid resistance determinants in Staphylococcus aureus clinical isolates
@ast
Fusidic acid resistance determinants in Staphylococcus aureus clinical isolates
@en
Fusidic acid resistance determinants in Staphylococcus aureus clinical isolates
@nl
type
label
Fusidic acid resistance determinants in Staphylococcus aureus clinical isolates
@ast
Fusidic acid resistance determinants in Staphylococcus aureus clinical isolates
@en
Fusidic acid resistance determinants in Staphylococcus aureus clinical isolates
@nl
prefLabel
Fusidic acid resistance determinants in Staphylococcus aureus clinical isolates
@ast
Fusidic acid resistance determinants in Staphylococcus aureus clinical isolates
@en
Fusidic acid resistance determinants in Staphylococcus aureus clinical isolates
@nl
P2860
P50
P356
P1476
Fusidic acid resistance determinants in Staphylococcus aureus clinical isolates
@en
P2093
Hsiao-Jan Chen
Wei-Chun Hung
P2860
P304
P356
10.1128/AAC.00523-10
P407
P577
2010-09-20T00:00:00Z